Innovent Announces Phase 2 Clinical Study Of Picankibart (IBI112) In Chinese Patients With Ulcerative Colitis Met Primary Endpoint
This study aims to evaluate the efficacy and safety of picankibart for the treatment of moderately to severely active ulcerative colitis (modified Mayo score of 4 to 9 with an endoscopic subscore of ...
Wellness Wednesday: Removing the stigmas surrounding plaque psoriasis
More than 6 million adults in the US live with plaque psoriasis, but it’s often a misunderstood disease. Joining the ...
FiercePharma18h
Johnson & Johnson sets 'new standard in inclusive marketing' with diverse Tremfya psoriasis ad
Though psoriasis affects people of all skin tones, that diversity isn’t always represented in portrayals of the condition in ...
optometryadvisor2d
Machine Learning Shows Promise in Assessing Psoriasis Severity
Machine learning models may be a useful tool for psoriasis severity assessment in clinical settings, despite a need for further research.
Pharmaceutical Technology5d
South Korean company Dong-A ST wins FDA approval for Stelara biosimilar
Imuldosa is the latest FDA-approved biosimilar of J&J’s blockbuster therapy for the treatment of certain autoimmune diseases.
La La Anthony Gets Real About How Plaque Psoriasis Has Affected Her Life
The actress and entertainment personality partnered with Amgen to share candid glimpses of how she lives with her medical condition.